Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GNRHR | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | UBQLNL | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
mRNA | BEX2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | NSDHL | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | GSK3A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | GSPT1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | NPM1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
mRNA | CAPN5 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | LINGO3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |